Skip to content

Endoscopic surgery versus conservative treatment for moderate volume hematoma in spontaneous basal ganglia heamorrhage, a randomized controlled trial

Endoscopic surgery versus conservative treatment for moderate volume hematoma in spontaneous basal ganglia heamorrhage, a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001614
Enrollment
Unknown
Registered
2011-09-29
Start date
2011-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spontaneous basal ganglia heamorrhage

Interventions

A:Hematoma evacuation by neuroendoscope +best medication
B:Best medical treatment

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Spontaneous basal ganglia hemorrhage confirmed by computed tomography(CT); 2. The volume of the hematoma is between 20ml to 40ml. Small intraventricular hemorrhage is not counted; 3. Admission within 36 hours from the ictus; 4. Age between 15 to 75 years old; 5. Glasgow Coma Score(GCS) >=8.

Exclusion criteria

Exclusion criteria: 1. Any sign of brain herniation, including deep coma, unilateral or bilateral pupil dilation, abnormal posture, or unstable vital signs; 2. Hemorrhage caused by aneurysm, vascular malformations, tumor apoplexy, trauma, or cerebral infarction. Computed tomography angiography will be performed; 3. Large intraventricular hematomas which occupy half of the cross section area of the lateral ventricle on CT scans, or hydrocephalus caused by hematocele; 4. Primary intraventricular hemorrhage; 5. Dysfunction of blood coagulation, thrombocytopenia, or history of taking any kind of drugs which affect coagulation function in the past 40 days; 6. Before the ictus, the patient has severe physical or mental illness which causes significant disability, or the patient has other severe comorbidity; 7. The patient is pregnant.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale(mRS);

Secondary

MeasureTime frame
National Institutes of Health Stroke Scale(NIHSS);Mortality;

Countries

China

Contacts

Public ContactChao You
youchao@mail.sc.cninfo.net+86 18980601505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 26, 2026